Oncotelic Therapeutics OTLC
OTC OTLC
$0.02 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Oncotelic Therapeutics (OTLC) Short-term Investments (2016 - 2017)

Updated

Oncotelic Therapeutics (OTLC) reported Short-term Investments of $2.3 million for Q1 2017, down 81.7% from $12.61 million a year earlier and down 72.9% from the prior quarter.

Analysis

Oncotelic Therapeutics (OTLC) Short-term Investments (2016 - 2017) Analysis & Trends

At the end of FY2016, Oncotelic Therapeutics posted Short-term Investments of $8.51 million.

  • Per Business Quant data, the three quarters before Q1 2017 came in at $8.51 million (Q4 2016), $11.11 million (Q3 2016) and $11.4 million (Q2 2016).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Oncotelic Therapeutics 7.20 Mn 6.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 2.30 Mn
Dec 31, 2016 8.51 Mn
Sep 30, 2016 11.11 Mn
Jun 30, 2016 11.40 Mn
Mar 31, 2016 12.61 Mn
API Access

Oncotelic Therapeutics Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=OTLC&period=max&api_key=YOUR_API_KEY